Sort
78,016 grants matching “breast cancer”
CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME
$1,500,903Mara Becker · Duke University · N01 · FY2021 · HD
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
$1,500,497Christina N Curtis · Stanford University · U54 · FY2025 · CA
NHGRI/DIR Genomics Core
$1,500,427Andreas Baxevanis · National Human Genome Research Institute · Z01 · FY2008 · HG
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
$1,500,330Brian E Henderson · University Of Southern California · P01 · FY2009 · CA
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
$1,500,153Lynn M Matrisian · Vanderbilt University · U54 · FY2008 · CA
TAS::75 0849::TAS; SBIR TOPIC 255, PHASE II "A STRADOBODY DIRECTED AGAINST LOW E
$1,500,000Henrik Olsen · Gliknik, Inc. · N44 · FY2011 · CA
99mTc-Tilmanocept for Sentinel Lymph Node Biopsy in Cervical Cancer Surgeries
$1,500,000David Allen Ralph · Navidea Biopharmaceuticals, Inc. · R44 · FY2015 · CA
PROSPR Statistical Coordinating Center (PSCC)
$1,500,000Ziding Feng · Fred Hutchinson Cancer Research Center · U01 · FY2011 · CA
Support for Specimen Banking in ACOSOG
$1,500,000Monica M Bertagnolli · Brigham And Women'S Hospital · U24 · FY2012 · CA
JOHNS HOPKINS CENTER FOR CANCER COMPLEMENTARY MEDICINE
$1,500,000Johns Hopkins University · P50 · FY2000 · AT
Emory Molecular and Translational Imaging Center
$1,500,000Carolyn C. Meltzer · Emory University · P50 · FY2010 · CA
Baylor College of Medicine Cancer Center
$1,500,000C Kent Osborne · Baylor College Of Medicine · P30 · FY2007 · CA
Southern Community Cohort Study
$1,500,000William J. Blot · Vanderbilt University · R01 · FY2006 · CA
CardioOnco-AI: AI-Empowered Cardiotoxicity Risk Prediction Among Breast Cancer Survivors Using Multi-Site Real-World Data
$1,499,995Rui Zhang · University Of Minnesota · U01 · FY2025 · FD
IGF::OT::IGF SBIR PHASE II, TOPIC 331: BIOPSY OPTICAL SENSOR FOR IN SITU TISSUE ANALYSIS
$1,499,984Jesus Delgado Alonso · Intelligent Optical Systems, Inc. · N44 · FY2016 · CA
OTHER FUNCTIONS TOPIC 276-"CHEMOLIEVE: DIFFERENTIAL PROTECTION OF NORMAL VERSUS
$1,499,963Todd Morgan · L-Nutra, Inc. · N44 · FY2012 · CA
Integration of ER-related signaling in breast cancer
$1,499,599Robert R. Clarke · Georgetown University · U54 · FY2010 · CA
NHGRI/DIR Cytogenetics and Microscopy Core
$1,499,541Amalia Dutra · National Human Genome Research Institute · ZIC · FY2018 · HG
TAS::75 0849 - TOPIC 255 PHASE II, CGMP MANUFACTURE OF A NOVEL CEA EXPRESSING A
$1,499,001Frank R. Jones · Etubics Corporation · N44 · FY2011 · CA
Howard/Hopkins Cancer Center Partnership
$1,498,812Howard University · U54 · FY2002 · CA
CIDR - UPGRADE WHOLE GENOME SEQUENCING ON 2,294 EXPERIMENTAL DNA SAMPLES FOR NCI, BEEBE-DIMMER
$1,498,500Kimberly F Doheny · Johns Hopkins University · N01 · FY2023 · HL
RNA TRASFECTED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY
$1,497,862Duke University · P01 · FY2002 · CA
SYNERGISTIC MULTIMODALITY ANTIBODY THERAPY
$1,497,565University Of California Davis · P01 · FY2000 · CA
KT-1 PAIRED WITH MULTIVALENT POLYMER-ANTI-PD-L1 PEPTIDE HYBRID: A SYNERGISTIC CHEMOIMMUNOTHERAPY FOR TREATMENT OF TRIPLE-NEGATIVE AND METASTATIC BREAST CANCER
$1,497,526University Of Utah · · FY2020 · Defense Health Agency
Epidemiologic Field Studies
$1,496,843Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA